of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing, regardless of any general incorporation language in any such filing, unles…

Chief Executive Officer — Craig Wichner: Craig Wichner was promoted to Chief Executive Officer.

of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing, regardless of any general incorporation language in any such filing, unles…

Director — Thomas Urban: Appointment of Thomas Urban as a member of the Board.

Other Events. On March 25, 2026, Cibus, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with BTIG, LLC, as the sole underwriter (the “Underwriter”), relating to the underwritten public offering (the “Offering”) of 6,976,744 shares (each a “Share” and collectively, the “Shares”) of the Company’s Class A common stock, par value $0.0001 per share (“Class A Common Stock”), at a public offering price of $2.15 per Share. In addition, the Company granted th…

of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing, regardless of any general incorporation language in any such filing, unles…

Other Events. On January 29, 2026, Cibus, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with BTIG, LLC, as the sole underwriter (the “Underwriter”), relating to the underwritten public offering (the “Offering”) of 13,333,333 shares (each a “Share” and collectively, the “Shares”) of the Company’s Class A common stock, par value $0.0001 per share (“Class A Common Stock”), at a public offering price of $1.50 per Share. Members of the Company’s board o…

Other Events. In connection with its underwritten offering announced today, Cibus, Inc. (“Cibus” or the “Company”) is providing the following disclosures, which update and supplement the Company’s existing business disclosures, as follows: Company Overview We are a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits, which are specific genetic characteristics in the DNA of a plant’s seed. These plant traits, or characteristics, in…

of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing, regardless of any general incorporation language in any such filing, unles…

Director — Craig Wichner: Craig Wichner was appointed as a new member of the Board and will also serve on the Strategy Committee.

Chief Financial Officer — Cornelis (Carlo) Broos: Cornelis (Carlo) Broos was promoted to Chief Financial Officer from Interim Chief Financial Officer.

Director — Kimberly A. Box: Appointment of Kimberly A. Box to the Board and various committees.

of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing, regardless of any general incorporation language in any such filing, unles…

Costs Associated with Exit or Disposal Activities. On July 21, 2025, the Board of Directors of Cibus, Inc. (the “Company” or “Cibus”) approved a reduction in workforce of approximately 34 full-time employees as a pivotal step in implementing the Company’s previously announced streamlined business focus, prioritizing its nearest-term and currently funded commercial opportunities. The Company expects that the reduction in workforce will be completed by December 31, 2025, and estimates that it w…

Entry into a Material Definitive Agreement. Securities Purchase Agreements In connection with an SEC-registered public offering (the “Offering”) of 15,714,285 shares (the “Shares”) of the Class A Common Stock, $0.0001 par value per share (the “Class A Common Stock”), of Cibus, Inc. (“the “Company”), on June 5, 2025, the Company entered into Securities Purchase Agreements (each a “Purchase Agreement” and collectively, the “Purchase Agreements”) with certain outside investors (the “SPA Investor…

The filing is about the approval of a stock purchase plan, not a management change.

of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing, regardless of any general incorporation language in any such filing, unles…

The filing pertains to a salary adjustment, not a management change.

of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing, regardless of any general incorporation language in any such filing, unles…

Chief Executive Officer — Rory Riggs: Mr. Riggs resigned as the Chief Executive Officer.

Entry into a Material Definitive Agreement. Securities Purchase Agreement On January 21, 2025, Cibus, Inc. (the “Company”) entered into Securities Purchase Agreements (each a “Purchase Agreement” and collectively, the “Purchase Agreements”) with various certain outside investors (the “Investors”) as well as Rory Riggs, the Company’s chief executive officer (together with the Investors, the “Purchasers”). Pursuant to the Purchase Agreements, the Company agreed to issue and sell, in a registere…

The filing pertains to a compensatory arrangement and does not involve any change in management or board composition.

Director — August Moretti: Mr. August Moretti was appointed as a member of the Board and will also serve on the Audit Committee.

of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing, regardless of any general incorporation language in any such filing, unles…

Costs Associated with Exit or Disposal Activities. On October 16, 2024, the Board of Directors of Cibus, Inc. (the “ Company ” or “ Cibus ”) approved a strategic realignment, which includes an immediate reduction in workforce of approximately 26 full-time employees. The Company estimates that it will incur approximately $0.35 million of one-time costs in the fourth quarter of 2024 in connection with this reduction in workforce, primarily related to accrued vacation and severance payments. The…